more difficult to model and study in animals. These techbeing actively used or a symptom occurs. Several MR studies have attempted to localize specific symptoms niques permit the study of neuroanatomy, neurotransto specific brain regions and have noted relationships mission, neurochemistry, and neurophysiology. They between symptoms and decreased size: e.g., disorgaalso avoid many of the disadvantages of using postmornized speech and the planum temporale or hallucinatem tissue, such as the potential contamination of findtions and the superior temporal gyrus (Barta et al., 1990 ; ings by effects of aging, previous treatment, tissue Shenton et al., 1992) . A recent innovative study by Silberfixation, or preservation. The application of these techsweig et al. (1995) used PET to examine the neural subniques has complemented earlier work in neuropharmastrates of hallucinations in schizophrenia by capturing cology by permitting the direct study of the effects of serial snapshots of brain blood flow at the moment when drugs on brain function. It has also given neuropatholpatients reported hearing voices. Although this study ogy a new impetus by facilitating the study of links bebegan with a single specific symptom, the investigative tween symptoms and specific abnormalities in brain retrail led the group to identify a complex distributed cirgions, as anticipated by Kraepelin and his colleagues.
cuit that was active during hallucinations; this circuit included subcortical regions (thalamus, caudate, and Localizing the Symptoms of Schizophrenia: putamen), anterior cingulate, and limbic cortex (hippoFocal or Distributed?
campus and parahippocampal gyrus). They note that The symptoms of schizophrenia are multiple, as is sumtheir findings support a mechanism for auditory hallucimarized in Table 1 . They are often divided into two nations that is based in deep brain structures, rather groups: positive (involving excess or distortion of normal than a mechanism reflecting "inner speech" deriving functions) and negative (involving loss or diminution of from cortical language regions such as Broca's area. normal functions). Positive symptoms include hallucinaAn alternative "top down" strategy seeks at the outset tions (abnormal perceptions occurring in the absence of to identify a fundamental cognitive process and/or crua stimulus), delusions (abnormal inferences from normal cial region or circuit that could account for the entire perceptions), disorganized speech, and disorganized range of heterogeneous symptoms observed. Examples behavior (ranging from motor abnormalities to inapproof such fundamental processes include defects in inforpriate social behavior). Negative symptoms include loss mation processing, attention, or working memory. Exof volition and drive, loss of fluency of thought and amples of crucial regions include prefrontal cortex language (alogia), and diminution in the ability to express (based on its complex patterns of connectivity and phyemotions (blunted affect). No single one of these symplogenetic expansion in human beings) and the thalamus toms occurs in all patients, but all occur in some pa-(based on its role as a filter or generator and its extensive tients. An illness of this type is called "polythetic", that connectivity; Andreasen et al., 1994a Andreasen et al., , 1994b . A subis it is not defined or characterized by a single defining stantial literature has been amassed in support of both feature. The challenge to investigators seeking the anatomic and physiologic dysfunction in the prefrontal mechanisms of schizophrenia is to identify a pathophyscortex, using MR, SPECT, PET, and postmortem tissue; iological process that could account for this diversity of some of these studies have proposed that a defect in symptoms. This involves determining whether the illness working memory could be mediated through prefrontal is due to a single focal lesion in a key region or to multiple abnormalities and would parsimoniously account for the focal lesions that vary from patient to patient and reflect basic cognitive deficit (Goldman-Rakic, 1994) . Several the variability in clinical presentation that is observed recent studies have noted decreased prefrontal size and in patients. Two strategies are currently being pursued cortical volume. Exemplifying the resurgence of interest to investigate this issue.
in neuropathology, a recent well-designed study of post-A "bottom up" strategy applies the traditional localizamortem tissue by Selemon et al. (1995) has found that tion approaches developed by nineteenth century Eurothe decreased size may be due to a decrease in prefronpean neurologists and expanded by Norman Geschtal neuropil, an abnormality that suggests an underlying wind; this strategy focuses on a key symptom, such neurodevelopmental mechanism. Recent studies also as hallucinations, and seeks to identify specific brain support a role for the thalamus in schizophrenia based regions that produce the symptom. Historically, this apon both MR and postmortem data (Andreasen et al., proach has used the reverse localization inherent in the 1994a). Impaired thalamic function or a misconnection lesion method: identifying brain regions involved in spebetween it and other key brain regions could lead to cific cognitive processes by seeing what is lost when defects in sensory gating, information processing, moddamage occurs. More recently, neuroimaging techulation or integration of information transfer, or other niques have permitted direct localization, allowing infundamental cognitive processes. Since the thalamus vestigators to correlate regions that have altered funcand prefrontal cortex are closely interlinked, this connection is often viewed a key candidate circuit. Other tional activity or structure when a cognitive process is cortical and subcortical regions have also been explored in more complex circuit models including almost all brain regions: temporal and parietal cortex, basal ganglia, anterior cingulate, and the hippocampal complex (Barta et al., 1990; Benes, 1995; Liddle et al., 1992; Shenton et al., 1992) . Evidence is available to support a role for most of these regions, and key experiments during coming years will no doubt eventually determine how focal or distributed the abnormalities in schizophrenia actually are.
Chemical Versus Anatomical Mechanisms
Contemporary investigators of schizophrenia also debate as to whether the disease should be conceptualized as a chemical or anatomical defect. The impressive efficacy of antipsychotic drugs led several generations of clinical investigators to view schizophrenia as a "dopamine disease." Primary emphasis was placed on determining the site of abnormality in the cascade of events modulating presynaptic signal formation and release and postsynaptic transduction. For many years, most investigators thought of the brain as a homogeneous soup, all parts of which were equally affected by disease processes and by neuroleptic medications used to treat them. The developing specialty of chemical anatomy slowly demonstrated, however, that concentrations of neurotransmitters vary across brain regions; this integration of chemistry with anatomy has also slowly affected models of schizophrenia. For example, as shown in Figure 1 , dopamine has a relatively narrow anatomic distribution in comparison with serotonin, suggesting that it may have more targeted effects on frontal and limbic regions, while serotonin may have a more global or modulatory effect. Further, subtypes of receptors (e.g., the D1/D5 family and the D2/D3/D4 family) also differ in their distribution. Contemporary thinking has progressed, therefore, from a "too much or too little The dopamine system (A) projects relatively selectively to limbic and inhibitory interactions between multiple neurotransregions, basal ganglia, and prefrontal cortex, while the serotonin mitters, including both GABA and glutamate in addition system (B) has an extensive cortical distribution. Early versions of to the classical biogenic amines (e.g., Carlsson and the dopamine hypothesis suggested that therapeutic effects of Carlsson, 1990; Lieberman et al., 1993; Benes, 1995) . drugs occurred through limbic blockade, while side effects were Dolan et al. (1995) recently reported a study that is caused by blockade in basal ganglia and perhaps prefrontal cortex. A specific D2 blocker for limbic regions was therefore hypothesized an example of this type of integrative approach. This to be the ideal medication. Current views, based on the efficacy of particular study examined the dopamine system in atypical neuroleptics, suggest that a mixed profile affecting multiple schizophrenia within the context of dual stimulations: transmitter systems may be more beneficial in reducing both sympthe cognitive challenge of performing a verbal fluency toms and side effects.
task and a chemical stimulation with apomorphine (a dopamine agonist). Normal individuals showed increased blood flow in a prefrontal-thalamic-cingulate or integrative effects on a variety of other cortical regions (e.g., frontal or temporal). This study illustrates well how circuit during this task, while the patients had a failure of activation that appeared to be localized to the anterior contemporary research on the mechanisms of schizophrenia can attempt to understand the illness on multicingulate; this failure was reversed, however, when they were given apomorphine. The anterior cingulate is a key ple levels simultaneously, combining cognition, chemistry, and anatomy to create an interactive model of the region that has recently received considerable attention in studies of both cognition and schizophrenia. For exdisorder that is consistent with findings observed in other laboratories. ample, it is active in a variety of different cognitive tasks, such as recognition memory for words, facial recognition, episodic memory, or story recall (Figure 2 ). Both
Coalescence and Consensus Schizophrenia is a devastating illness that affects 1% PET and postmortem studies have suggested that abnormalities in this region may occur in schizophrenia.
of the population worldwide. Understanding of its mechanisms was handicapped for many years by the belief As Dolan et al. point out, it may have crucial modulatory that it was a "psychological" illness, even though it was Wible, C.G., Hokama, H., Martin, J., Metcalf, D., and Coleman, M.
originally described as a brain disease by Kraepelin and (1992) . N. Engl. J. Med. 327, [604] [605] [606] [607] [608] [609] [610] [611] [612] others. Research on schizophrenia has returned to its Silbersweig, D.A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grooroots in neuroscience; as a consequence, the study of toonk, S., Seaward, J., McKenna, P., Chua, S.E., Schnorr, L., Jones, its mechanisms has made enormous strides in recent T., and Frackowiak, R.S.J. (1995) . Nature 378, [176] [177] [178] [179] years. Although we are still far from a complete solution Weinberger, D.R., Berman, K.F., and Illowsky, B.P. (1988) . Arch.
of the schizophrenia puzzle, many pieces of the pattern Gen. Psychiatry 45, [609] [610] [611] [612] [613] [614] [615] have begun to fall into place.
